Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds

FEMS Microbiology Reviews

Volumn 27, Issue 2-3, 2003, Pages 341-353

  Silver, Simon ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Argyria; Burn infection; Plasmid resistance; Sil gene; Silver resistance; Silver sulfadiazine; Silver binding protein

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMALGAM; BACTERIAL DNA; BINDING PROTEIN; CHLORHEXIDINE GLUCONATE; CYTOPLASM PROTEIN; METHACRYLIC ACID; MILD SILVER PROTEIN; SILVAZINE; SILVER DERIVATIVE; SILVER PROTEIN; SILVER THIOSULFATE; SILVER ZEOLITE; SULFADIAZINE SILVER; UNCLASSIFIED DRUG;

ALLERGY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARGYRIA; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BANDAGE; BIOFILM; BURN; CATHETER; CHROMOSOME ANALYSIS; DIABETES MELLITUS; DNA DETERMINATION; DNA SEQUENCE; DRUG COATING; DRUG EFFECT; DRUG EFFICACY; DRUG MARKETING; DRUG SCREENING; DRUG SENSITIVITY; DRUG USE; ESCHERICHIA COLI; EUKARYOTE; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HYGIENE; MATERIAL COATING; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLASMID; PROTEIN BINDING; PROTEIN SYNTHESIS; REVIEW; SALMONELLA; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIDE EFFECT; SUSTAINED RELEASE PREPARATION; TRANSCRIPTION REGULATION; ULCER; WOUND;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ESCHERICHIA COLI K12; EUKARYOTA; SALMONELLA;

EID: 0037903225     PISSN: 01686445     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6445(03)00047-0     Document Type: Review

References (129)

1. Silver S. Bacterial resistances to toxic metal ions. Gene. 179:1996;9-19.
2. Silver S. Genes for all metals - a bacterial view of the Periodic Table. J. Ind. Microbiol. Biotechnol. 20:1998;1-12.
3. Silver S., Phung L.T. Bacterial heavy metal resistance: new surprises. Annu. Rev. Microbiol. 50:1996;753-789.
4. Hobman, J.L., Wilson, J.R. and Brown, N.L. (2000) Microbial mercury reduction. In: Environmental Metal-Microbe Interactions (Lovley, D.R., Ed.), pp. 177-197. ASM Press, Washington, DC.
5. Nies D.H. Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol. Rev. 27:2003;313-339.
6. Rensing C., Grass G. Escherichia coli mechanism of copper homeostasis in a changing environment. FEMS Microbiol. Rev. 27:2003;197-213.
7. Cavet J.S., Borrelly G.P.M., Robinson N.J. Zn, Cu and Co in cyanobacteria: selective control of metal availability. FEMS Microbiol. Rev. 27:2003;165-181.
8. Barkay T., Miller S.M., Summers A.O. Bacterial mercury resistance from atoms to ecosystems. FEMS Microbiol. Rev. 27:2003;355-384.
9. Schiering N., Kabsch W., Moore M.J., Distefano M.D., Walsh C.T., Pai E.F. Structure of the detoxification catalyst mercuric ion reductase from Bacillus sp. strain RC607. Nature. 352:1991;168-171.
10. Bennett M.S., Guan Z., Laurberg M., Su X.D. Bacillus subtilis arsenate reductase is structurally and functionally similar to low molecular weight protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA. 98:2001;13577-13582.
11. Martin P., DeMel S., Shi J., Rosen B.P., Edwards B.F.P. Insights into the structure, solvation, and mechanism of ArsC arsenate reductase, a novel arsenic detoxification enzyme. Structure. 9:2001;1071-1081.
12. Messens J., Martins J.C., Van Belle K., Brosens E., Desmyter A., De Gieter M., Wieruszeski J.M., Willem R., Wyns L., Zegers I. All intermediates of the arsenate reductase mechanism including an intramolecular dynamic disulfide bond cascade. Proc. Natl. Acad. Sci. USA. 99:2002;8506-8511.
13. Zegers I., Martins J.C., Willem R., Wyns L., Messens J. Arsenate reductase from S. aureus pI258 is a phosphatase drafted for redox duty. Nat. Struct. Biol. 8:2001;843-847.
14. Ellis P.J., Conrads T., Hille R., Kuhn P. Crystal structure of the 100 kDa arsenite oxidase from Alcaligenes faecalis in two crystal forms at 1.64 Å and 2.03 Å Structure. 9:2001;125-132.
15. Cook W.J., Kar S.R., Taylor K.B., Hall L.M. Crystal structure of the cyanobacterial metallothionein repressor SmtB: a model for metalloregulatory proteins. J. Mol. Biol. 275:1998;337-346.
16. Opella S.J., DeSilva T.M., Veglia G. Structural biology of metal-binding sequences. Curr. Opin. Chem. Biol. 6:2002;217-223.
17. Nies D.H. Microbial heavy-metal resistance. Appl. Microbiol. Biotechnol. 51:1999;730-750.
18. Gupta A., Matsui K., Lo J.F., Silver S. Molecular basis for resistance to silver cations in Salmonella. Nat. Med. 5:1999;183-188.
19. McHugh S.L. Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin. Lancet. i:1975;235-240.
20. Hendry A.T., Stewart I.O. Silver-resistant Enterobacteriaceae from hospital patients. Can. J. Microbiol. 25:1979;915-921.
21. Annear D.I., Mee B.J., Bailey M. Instability and linkage of silver resistance, lactose fermentation and colony structure in Enterobacter cloacae. J. Clin. Pathol. 29:1976;441-443.
22. Bridges K., Kidson A., Lowbury E.J.L., Wilkins M.D. Gentamicin- and silver-resistant Pseudomonas. Br. Med. J. 1:1979;446-449.
23. Belly R.T., Kydd G.C. Silver resistance in microorganisms. Dev. Ind. Microbiol. 23:1982;567-577.
24. Haefeli C., Franklin C., Hardy K. Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine. J. Bacteriol. 158:1984;389-392.
25. Deshpande L.M., Chopade B.A. Plasmid mediated silver resistance in Acinetobacter baumannii. Biometals. 7:1994;49-56.
26. Kaur P., Saxena M., Vadehra D.V. Plasmid mediated resistance to silver ions in Escherichia coli. Indian J. Med. Res. 82:1985;122-126.
27. Kaur P., Vadehra D.V. Mechanism of resistance to silver ions in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 29:1986;165-167.
28. Starodub M.E., Trevors J.T. Mobilization of Escherichia coli R1 silver-resistance plasmid pJT1 by Tn5-Mob into Escherichia coli C600. Biol. Met. 3:1990;24-27.
29. Starodub M.E., Trevors J.T. Silver resistance in Escherichia coli R1. J. Med. Microbiol. 29:1989;101-110.
30. Charley R.C., Bull A.T. Bioaccumulation of silver by a multispecies community of bacteria. Arch. Microbiol. 123:1979;239-244.
31. Pooley F.D. Bacteria accumulate silver during leaching of sulphide ore minerals. Nature. 296:1982;642-643.
32. Gadd G.M., Laurence O.S., Brisoue P.A., Trevors J.T. Silver accumulation by Pseudomonas stutzeri AG 259. Biol. Met. 2:1989;168-173.
33. Starodub M.E., Trevors J.T. Silver accumulation and resistance in Escherichia coli R1. J. Inorg. Biochem. 39:1990;317-325.
34. Slawson R.M., Trevors J.T., Lee H. Silver accumulation and resistance in Pseudomonas stutzeri. Arch. Microbiol. 158:1992;398-404.
35. Slawson R.M., Van Dyke M.I., Lee H., Trevors J.T. Germanium and silver resistance, accumulation and toxicity in microorganisms. Plasmid. 27:1992;72-79.
36. Gupta A., Silver S. Silver as a biocide: will resistance become a problem? Nat. Biotechnol. 16:1998;888.
37. Silver S., Lo J.-F., Gupta A. Silver cations as an antimicrobial agent: clinical uses and bacterial resistance. APUA Newsl. 17:1999;1-3.
38. Silver S., Gupta A., Matsui K., Lo J.-F. Resistance to Ag(I) cations in bacteria: environments, genes and proteins. Met.-based Drugs. 6:1999;315-320.
39. Clement J.L., Jarrett P.S. Antibacterial silver. Met.-based Drugs. 1:1994;467-482.
40. Monafo W.W., Freedman B. Topical therapy for burns. Surg. Clin. North Am. 67:1987;133-145.
41. Modak S.M., Sampath L., Fox C.L. Jr. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds. J. Burn Care Rehabil. 9:1988;359-363.
42. Fox C.L. Jr., Rao T.N., Azmeth R., Gandhi S.S., Modak S. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection. J. Burn Care Rehabil. 11:1990;112-117.
43. George N., Faoagali J., Muller M. Silvazine™ (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates. Burns. 23:1997;493-495.
44. Pruitt B.A. Jr., McManus A.T., Kim S.H., Goodwin C.W. Burn wound infections: current status. World J. Surg. 22:1998;135-145.
45. Sampath L.A., Chowdhury N., Caraos L., Modak S.M. Infection resistance of surface modified catheters with either short-lived or prolonged activity. J. Hosp. Infect. 30:1995;201-210.
46. Dasgupta M.K. Silver peritoneal catheters reduce bacterial colonization. Adv. Perit. Dial. 10:1994;195-198.
47. Gabriel M.M., Mayo M.S., May L.L., Simmons R.B., Ahearn D.G. In vitro evaluation of the efficacy of a silver-coated catheter. Curr. Microbiol. 33:1996;1-5.
48. Dasgupta M.K. Silver-coated catheters in peritoneal dialysis. Perit. Dial. Int. 17:(Suppl. 2):1997;S142-S145.
49. Becker R.O. Silver ions in the treatment of local infections. Met.-based Drugs. 6:1999;297-300.
50. Adams A.P., Santschi E.M., Mellencamp M.A. Antibacterial properties of a silver chloride-coated nylon wound dressing. Vet. Surg. 28:1999;219-225.
51. Swaim S.F., Lee A.H. Topical wound medications. J. Am. Vet. Med. Assoc. 190:1987;1588-1592.
52. Deitch E.A., Marino A.A., Malakanok V., Albright J.A. Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity. J. Trauma. 27:1987;301-304.
53. Chambers C.W., Proctor C.M., Kabler P.W. Bactericidal effect of low concentrations of silver. J. Am. Water Works Assoc. 54:1962;208-216.
54. Bell F.A. Review of effects of silver impregnated carbon filters on microbial quality of water. J. Am. Water Works Assoc. 83:1991;74-79.
55. Kool J.L., Bergmire-Sweat D., Butler J.C., Brown E.W., Peadbody D.J., Masi D.S., Carpenter J.C., Pruckler J.M., Benson R.F., Fields B.S. Hospital characteristics associated with colonization of water systems by Legionella and risk of nosocomial legionnaires' disease: a cohort study of 15 hospitals. Infect. Control Hosp. Epidemiol. 20:1999;798-805.
56. Fung M.C., Weintraub M., Bowen D.L. Colloidal silver proteins marketed as health supplements. J. Am. Med. Assoc. 274:1995;1196-1197.
57. Lück, E. and Jager, M., with S.F. Laichena (Translator) (1997) Silver. In: Antimicrobial Food Additives: Characteristics, Uses, Effects, 2nd revised edn., Chapter 7, pp. 70-72. Springer-Verlag, Berlin; ISBN: 354061138X.
58. Farber, M.P. (1997) The Micro Silver Bullet, 6th edn.
59. Metcalf, M. (2001) Colloidal Silver: Making the Safest and Most Powerful Medicine on Earth for the Price of Water, 4th edn. Mark Metcalf, Publisher (privately published), Forest Grove, OR; ISBN: 097086440X.
60. Brune D. Metal release from dental biomaterials. Biomaterials. 7:1986;163-175.
61. Lorscheider, F.L., Vimy, M.J. and Summers, A.O. (1995) Mercury exposure from 'silver' tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB J. 9, 504-508 and 499-500.
62. Liebert C.A., Wireman J., Smith T., Summers A.O. The impact of mercury released from dental 'silver' fillings on antibiotic resistances in the primate oral and intestinal bacterial flora. Met. Ions Biol. Syst. 34:1997;441-460.
63. Vimy M.J., Hooper D.E., King W.W., Lorscheider F.L. Mercury from maternal 'silver' tooth fillings in sheep and human breast milk. A source of neonatal exposure. Biol. Trace Elem. Res. 56:1997;143-152.
64. Heukeshoven J., Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis. 6:1985;103-112.
65. Gupta A., Maynes M., Silver S. The effects of halides on plasmid silver resistance in Escherichia coli. Appl. Environ. Microbiol. 64:1998;5042-5045.
66. Bragg P.D., Rainnie D.J. The effect of silver ions on the respiratory chain of Escherichia coli. Can. J. Microbiol. 20:1974;883-889.
67. Ghandour W., Hubbard J.A., Deistung J., Hughes M.N., Poole R.K. The uptake of silver ions by Escherichia coli K12: toxic effects and interaction with copper ions. Appl. Microbiol. Biotechnol. 28:1988;559-565.
68. Schreurs W.J.A., Rosenberg H. Effect of silver ions on transport and retention of phosphate by Escherichia coli. J. Bacteriol. 152:1982;7-13.
69. Gupta A., Phung L.T., Taylor D.E., Silver S. Silver resistance genes in plasmids of the IncH incompatibility group and on the Escherichia coli chromosome. Microbiology. 147:2001;3393-3402.
70. Franke S., Grass G., Nies D.H. The product of the ybdE gene of the Escherichia coli chromosome is involved in detoxification of silver ions. Microbiology. 147:2001;965-972.
71. Brown N.L., Barrett S.R., Camakaris J., Lee B.T.O., Rouch D.A. Molecular genetics and transport analysis of the copper-resistance determinant (pco) from Escherichia coli plasmid pRJ1004. Mol. Microbiol. 17:1995;1153-1166.
72. Lo, J.-F., Gordon, N., Gettins, P.G.W. and Silver, S. (2002) The silver binding protein SilE of plasmid-mediated silver resistance in Escherichia coli. Proc. Natl. Acad. Sci. USA, submitted.
73. Gupta A. RT-PCR: characterization of long multi-gene operons and multiple transcript gene clusters in bacteria. Biotechniques. 27:1999;966-972.
74. Nies, D.H. and Brown, N.L. (1997) Two-component systems in the regulation of heavy metal resistance. In: Metal Ions in Gene Regulation (Silver, S. and Walden, W., Eds.), pp. 77-103. Chapman and Hall, New York.
75. Nies D.H., Silver S. Ion efflux systems involved in bacterial metal resistances. J. Ind. Microbiol. 14:1995;186-199.
76. Nies D.H. The cobalt, zinc, and cadmium efflux system CzcABC from Alcaligenes eutrophus functions as a cation-proton antiporter in Escherichia coli. J. Bacteriol. 177:1995;2707-2712.
77. Rensing C., Pribyl T., Nies D.H. New functions for the three subunits of the CzcCBA cation-proton antiporter. J. Bacteriol. 179:1997;6871-6879.
78. Nies D.H., Nies A., Chu L., Silver S. Expression and nucleotide sequence of a plasmid-determined divalent cation efflux system from Alcaligenes eutrophus. Proc. Natl. Acad. Sci. USA. 86:1989;7351-7355.
79. Murakami S., Nakashima R., Yamashita E., Yamaguchi A. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature. 419:2002;587-593.
80. Solioz M., Odermatt A. Copper and silver transport by CopB-ATPase in membrane vesicles of Enterococcus hirae. J. Biol. Chem. 270:1995;9217-9221.
81. Solioz M., Vulpe C. CPx-type ATPases: a class of P-type ATPases that pump heavy metals. Trends Biochem. Sci. 21:1996;237-241.
82. Sharma R., Rensing C., Rosen B.P., Mitra B. The ATP hydrolytic activity of purified ZntA, a Pb(II)/Cd(II)/Zn(II)-translocating ATPase from Escherichia coli. J. Biol. Chem. 275:2000;3873-3878.
83. Rensing C., Fan B., Sharma R., Mitra B., Rosen B.P. CopA: an Escherichia coli Cu(I)-translocating P-type ATPase. Proc. Natl. Acad. Sci. USA. 97:2000;652-656.
84. Blencowe D.K., Morby A.P. Zn(II) metabolism in prokaryotes. FEMS Microbiol. Rev. 27:2003;219-311.
85. + and are deficient in porins. J. Bacteriol. 179:1997;6127-6132.
86. Peterson C.W., Narula S.S., Armitage I.M. 3D solution structure of copper and silver-substituted yeast metallothioneins. FEBS Lett. 379:1996;85-93.
87. Hoffman S. Silver sulfadiazine: an antibacterial agent for topical use in burns. Scand. J. Plast. Reconstr. Surg. 18:1984;119-126.
88. Modak S., Fox P., Stanford J., Sampath L., Fox C.L. Jr. Silver sulfadiazine-impregnated biologic membranes as burn wound covers. J. Burn Care Rehabil. 7:1986;422-425.
89. Monafo W.W., West M.A. Current treatment recommendations for topical burn therapy. Drugs. 40:1990;364-373.
90. Miller L., Hansbrough J., Slater H., Goldfarb I.W., Kealey P., Saffle J., Kravitz M., Silverstein P. Sildimac: a new delivery system for silver sulfadiazine in the treatment of full-thickness burn injuries. J. Burn Care Rehabil. 11:1990;35-41.
91. Wright J.B., Lam K., Burrell R.E. Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. Am. J. Infect. Control. 26:1998;572-577.
92. Matylevich N.P., Chu C.S., McManus A.T., Mason A.D. Jr., Pruitt B.A. Jr. Direct current reduces plasma protein extravasation after partial-thickness burn injury in rats. J. Trauma. 41:1996;424-429.
93. Chu C.S., McManus A.T., Matylevich N.P., Mason A.D. Jr., Pruitt B.A. Jr. Enhanced survival of autoepidermal-allodermal composite grafts in allosensitized animals by use of silver-nylon dressings and direct current. J. Trauma. 39:1995;273-278.
94. Chu C.S., Matylevich N.P., McManus A.T., Pruitt B.A. Jr., Goodwin C.W. Optimized mesh expansion of composite skin grafts in rats treated with direct current. J. Trauma. 43:1997;804-812.
95. Chu C.S., Matylevitch N.P., McManus A.T., Goodwin C.W., Pruitt B.A. Jr. Accelerated healing with a mesh autograft/allodermal composite skin graft treated - with silver nylon dressings with and without direct current in rats. J. Trauma. 49:2000;115-125.
96. Cook G., Costerton J.W., Darouiche R.O. Direct confocal microscopy studies of the bacterial colonization in vitro of a silver-coated heart valve sewing cuff. Int. J. Antimicrob. Agents. 13:2000;169-173.
97. Illingworth, B.L., Tweden, K., Schroeder, R.F. and Cameron, J.D. (1998) In vivo efficacy of silver-coated (Silzone) infection-resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis. J. Heart Valve Dis. 7, 524-530; see also comment by J.W. Costerton. 1999. In response to: In vivo efficacy of silver-coated (Silzone) infection- resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis. J. Heart Valve Dis. 8, 346-348.
98. Illingworth, B.L., Tweden, K., Schroeder, R.F. and Cameron, J.D. (1998) In vivo efficacy of silver-coated (Silzone) infection-resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis. J. Heart Valve Dis. 7, 524-530; see also comment by J.W. Costerton. 1999. In response to: In vivo efficacy of silver-coated (Silzone) infection- resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis. J. Heart Valve Dis. 8, 346-348.
99. Costerton J.W. In response to: In vivo efficacy of silver-coated (Sil-zone) infection-resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis. J. Heart Valve Dis. 8:1999;346-348.
100. Illingworth B., Bianco R.W., Weisberg S. In vivo efficacy of silver-coated fabric against Staphylococcus epidermidis. J. Heart Valve Dis. 9:2000;135-141.
101. Jansen B., Kohnen W. Prevention of biofilm formation by polymer modification. J. Ind. Microbiol. 15:1995;391-396.
102. Klaus T., Joerger R., Olsson E., Granqvist C.G. Silver-based crystalline nanoparticles, microbially fabricated. Proc. Natl. Acad. Sci. USA. 96:1999;13611-13614.
103. Greenfeld J.I., Sampath L., Popilskis S.J., Brunnert S.R., Stylianos S., Modak S. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Crit. Care Med. 23:1995;894-900.
104. Sampath L.A., Chowdhury N., Caraos L., Modak S.M. Infection resistance of surface modified catheters with either short-lived or prolonged activity. J. Hosp. Infect. 30:1995;201-210.
105. Boswald M., Girisch M., Greil J., Spies T., Stehr K., Krall T., Guggenbichler J.P. Antimicrobial activity and biocompatibility of polyurethane and silicone catheters containing low concentrations of silver: a new perspective in prevention of polymer-associated foreign-body-infections. Zent.bl. Bakteriol. 283:1995;187-200.
106. Boswald M., Lugauer S., Regenfus A., Braun G.G., Martus P., Geis C., Scharf J., Bechert T., Greil J., Guggenbichler J.P. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection. 27:(Suppl. 1):1999;S56-S60.
107. Dahlberg P.J., Agger W.A., Singer J.R., Yutuc W.R., Newcomer K.L., Schaper A., Rooney B.L. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect. Control Hosp. Epidemiol. 16:1995;506-511.
108. Jansen B., Kohnen W. Prevention of biofilm formation by polymer modification. J. Ind. Microbiol. 15:1995;391-396.
109. Darouiche R.O. Anti-infective efficacy of silver-coated medical prostheses. Clin. Infect. Dis. 29:1999;1371-1377.
110. Darouiche, R.O., Raad, I.I., Heard, S.O., Thornby, J.I., Wenker, O.C., Gabrielli, A., Berg, J., Khardori, N., Hanna, H., Hachem, R., Harris, R.L. and Mayhall, G. (1999) A comparison of two antimicrobial-impregnated central venous catheters. New Engl. J. Med. 304, 1-8, and correspondence pp. 1761-1762.
111. Gatter N., Kohnen W., Jansen B. In vitro efficacy of a hydrophilic central venous catheter loaded with silver to prevent microbial colonization. Zent.bl. Bakteriol. 287:1998;157-169.
112. Bender, M.T. (2002) Dentist the Menace. Mercury Policy Project/Tides Center, Montpelier, VT and HealthCare Without Harm, Washington, DC, 18 pp. www.amalgam.org, www.mercurypolicy.org and www.noharm.org .
113. de Cerreno, A.L.C., Panero, M. and Boehme, S. (2002) Pollution Prevention and Management Strategies for Mercury in the New York/New Jersey Harbor. New York Academy of Sciences, New York. ( http://www.nyas.org/policy/harbor/ ).
114. Smith T., Pitts K., McGarvey J.A., Summers A.O. Bacterial oxidation of mercury metal vapor, Hg(0). Appl. Environ. Microbiol. 64:1998;1328-1332.
115. Sanders J.G., Abbe G.R., Riedel G.F. Silver uptake and subsequent effects on growth and species composition in an estuarine community. Sci. Total Environ. 97-98:1990;761-769.
116. Bouts B.A. Argyria. New Engl. J. Med. 340:1999;1554.
117. Hanada K., Hashimoto I., Kon A., Kida K., Mita R. Silver in sugar particles and systemic argyria. Lancet. 351:1998;960.
118. Legat F.J., Goessler W., Schlagenhaufen C., Soyer H.P. Argyria after short-contact acupuncture. Lancet. 352:1998;241.
119. Fung M.C., Bowen D.L. Silver products for medical indications: risk-benefit assessment. J. Toxicol. Clin. Toxicol. 34:1996;119-126.
120. Gibbs, R.J. (1999) Silver Colloids - Do They Work? R. Gibbs Publisher; ISBN: 0967699207.
121. Silverseed, J. (2001) Colloidal Silver: Antibiotic Superhero. Mad as Hell Press; ISBN: 0970825609.
122. Farber, M.P. (1997) The Micro Silver Bullet, 6th edn.
123. Garfield, E. (1982) The legacy of Albert C. Barnes, Parts 1 and 2. Current Contents #5, 5-12 and #12, 5-13.
124. Windholz, M., Budavari, S., Blumetti, R.F. and Oteerbein, E.S. (1983) Merck Index, 10th edn. Merck and Co., Rahway, NJ.
125. Weast, R.C. (1968) Solubility product. In: CRC Handbook of Chemistry and Physics, 49th edn., p. B307. The Chemical Rubber Company, Cleveland, OH.
126. Klasen H.J. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns. 26:2000;131-138.
127. Lansdown A.B.G., Sampson B., Laupattarakasem P., Vuttivirojana A. Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat. Brit. J. Dermatol. 137:1997;728-735.
128. Inoue Y., Hoshino M., Takahashi H., Noguchi T., Murata T., Kanzaki Y., Hamashima H., Sasatsu M. Bactericidal activity of Ag-zeolite mediated by reactive oxygen species under aerated conditions. J. Inorg. Biochem. 92:2002;37-42.
129. Kawahara K., Tsuruda K., Morishita M., Uchida M. Antibacterial effect of silver-zeolite on oral bacteria under anaerobic conditions. Dental Materials. 16:2000;452-455.